LifeStance Health (LFST) Receivables - Other (2021 - 2025)

LifeStance Health (LFST) has 5 years of Receivables - Other data on file, last reported at $3.8 million in Q4 2025.

• Receivables - Other for Q4 2025 came in at $3.8 million, up 1599.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.8 million (up 1599.55% YoY), and the FY2025 annual result was $3.8 million, up 1599.55% from the prior year.
• Receivables - Other climbed to $3.8 million in Q4 2025 per LFST's latest filing, from $223000.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $19.3 million in Q4 2021 and troughed at $223000.0 in Q4 2024.
• A 5-year average of $4.7 million and a median of $3.8 million in 2025 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2025: Receivables - Other plunged 96.68% in 2022, then soared 1599.55% in 2025.
• A 5-year view of Receivables - Other shows it stood at $19.3 million in 2021, then sank by 96.68% to $640000.0 in 2022, then tumbled by 63.28% to $235000.0 in 2023, then retreated by 5.11% to $223000.0 in 2024, then soared by 1599.55% to $3.8 million in 2025.
• Business Quant data shows LFST's Receivables - Other at $3.8 million in Q4 2025, $223000.0 in Q4 2024, and $235000.0 in Q4 2023.